Client News

AATec to Present Data from Lead Candidate ATL-105 at World Bronchiectasis Conference 2026

PL BioScience Appoints Maik W. Jornitz to Board of Directors

AFYREN reports concrete progress in industrial ramp-up: notable increase in sales in the first half of 2026

Servier Deutschland: 30 Jahre langfristiges Engagement für Patientinnen und Patienten

AFYREN’s impact-driven bioeconomy model confirmed by B Corp™ certification

Ipsens Dysport® zeigt in Head-to-Head-Studie mit Botox® längere Wirkdauer bei Erwachsenen mit Spastizität der oberen Extremitäten

World Bronchiectasis Conference 2026 Returns to Hannover: 10 Years of Progress from Neglected Disease to Global Movement

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Topadur Pharma AG Adds Senior Board Expertise with Appointment of Dr. Felix R. Ehrat and Dr. Peter Jager